<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Lipids Health Dis</journal-id><journal-title>Lipids in Health and Disease</journal-title><issn pub-type="epub">1476-511X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1476-511X-7-15</article-id><article-id pub-id-type="pmid">18426603</article-id><article-id pub-id-type="doi">10.1186/1476-511X-7-15</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Synergistic effects of high fat feeding and apolipoprotein E deletion on enterocytic amyloid-beta abundance</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Galloway</surname><given-names>Susan</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>susan.galloway@postgrad.curtin.edu.au</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Pallebage-Gamarallage</surname><given-names>Menuka MS</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>mmenuka@hotmail.com</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Takechi</surname><given-names>Ryusuke</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>ryusuke.takechi@postgrad.curtin.edu.au</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Jian</surname><given-names>Le</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>L.Jian@Curtin.edu.au</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Johnsen</surname><given-names>Russell D</given-names></name><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref><email>rjohnsen@cyllene.uwa.edu.au</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Dhaliwal</surname><given-names>Satvinder S</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>S.Dhaliwal@Curtin.edu.au</email></contrib><contrib id="A7" corresp="yes" contrib-type="author"><name><surname>Mamo</surname><given-names>John CL</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>J.Mamo@Curtin.edu.au</email></contrib></contrib-group><aff id="I1"><label>1</label>School of Public Health and Australian Technology Network (ATN), Centre for Metabolic Fitness, Curtin University of Technology, Perth, Western Australia</aff><aff id="I2"><label>2</label>Australian Neuromuscular Research Institute, QEII Medical Centre, Perth, Western Australia</aff><aff id="I3"><label>3</label>Centre for Neuromuscular and Neurological Disorders, University of Western Australia</aff><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>22</day><month>4</month><year>2008</year></pub-date><volume>7</volume><fpage>15</fpage><lpage>15</lpage><ext-link ext-link-type="uri" xlink:href="http://www.lipidworld.com/content/7/1/15"/><history><date date-type="received"><day>29</day><month>1</month><year>2008</year></date><date date-type="accepted"><day>22</day><month>4</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 Galloway et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2008</copyright-year><copyright-holder>Galloway et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Galloway Susan susan.galloway@postgrad.curtin.edu.au </dc:author><dc:title> Synergistic effects of high fat feeding and apolipoprotein E deletion on enterocytic amyloid-beta abundance </dc:title><dc:date>2008</dc:date><dcterms:bibliographicCitation>Lipids in Health and Disease 7(1): 15-. (2008)</dcterms:bibliographicCitation><dc:identifier type="sici">1476-511X(2008)7:1&#x0003c;15&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1476-511X</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Amyloid-&#x003b2; (A&#x003b2;), a key protein found in amyloid plaques of subjects with Alzheimer's disease is expressed in the absorptive epithelial cells of the small intestine. Ingestion of saturated fat significantly enhances enterocytic A&#x003b2; abundance whereas fasting abolishes expression. Apolipoprotein (apo) E has been shown to directly modulate A&#x003b2; biogenesis in liver and neuronal cells but it's effect in enterocytes is not known. In addition, apo E modulates villi length, which may indirectly modulate A&#x003b2; as a consequence of differences in lipid absorption. This study compared A&#x003b2; abundance and villi length in wild-type (WT) and apo E knockout (KO) mice maintained on either a low-fat or high-fat diet. Wild-type C57BL/6J and apo E KO mice were randomised for six-months to a diet containing either 4% (w/w) unsaturated fats, or chow comprising 16% saturated fats and 1% cholesterol. Quantitative immunohistochemistry was used to assess A&#x003b2; abundance in small intestinal enterocytes. Apo E KO mice given the low-fat diet had similar enterocytic A&#x003b2; abundance compared to WT controls.</p></sec><sec><title>Results</title><p>The saturated fat diet substantially increased enterocytic A&#x003b2; in WT and in apo E KO mice, however the effect was greater in the latter. Villi height was significantly greater in apo E KO mice than for WT controls when given the low-fat diet. However, WT mice had comparable villi length to apo E KO when fed the saturated fat and cholesterol enriched diet. There was no effect of the high-fat diet on villi length in apo E KO mice.</p></sec><sec><title>Conclusion</title><p>The findings of this study are consistent with the notion that lipid substrate availability modulates enterocytic A&#x003b2;. Apo E may influence enterocytic lipid availability by modulating absorptive capacity.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Net concentration of cerebral A&#x003b2; is determined by the presence of apolipoprotein (apo) E with a dose dependent gene effect of apo E -/- &#x0003c; apo E -/+ &#x0003c; apo E +/+ on hippocampal senile plaques [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Animals and cell culture studies show that apo E regulates the production, transport, clearance and solubility of A&#x003b2; [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B8">8</xref>]. Apolipoprotein E may modulate cerebral A&#x003b2; homeostasis by regulating cerebral A&#x003b2; efflux via the low-density-lipoprotein-receptor-related protein (LRP), relative to the influx of A&#x003b2; via transporters such as the receptor for advanced-glycation-end-products (RAGE) [<xref ref-type="bibr" rid="B9">9</xref>]. In addition, apo E can also directly influence A&#x003b2; biogenesis via regulation of &#x003b1;- and &#x003b2;-secretases activity [<xref ref-type="bibr" rid="B10">10</xref>], or indirectly, by influencing the intracellular pool of regulating lipids [<xref ref-type="bibr" rid="B11">11</xref>].</p><p>Apolipoprotein E critically regulates cholesterol metabolism and lipid homeostasis. The apo E protein is the primary receptor ligand for dietary-derived lipoproteins synthesized by the small intestine (chylomicrons) and triglyceride-rich lipoproteins (very-low-density lipoproteins (VLDL)), synthesized from liver [<xref ref-type="bibr" rid="B12">12</xref>]. Several lines of evidence support a link between aberrations in lipid metabolism and AD risk [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B13">13</xref>]. Epidemiological and clinical studies suggest that a high intake of saturated fat and/or cholesterol accelerate onset and progression of AD, whereas some polyunsaturated fatty acids may be protective [<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B17">17</xref>]. Moreover, strong evidence of a causal relationship between dietary fats and AD comes from feeding studies in mice or rabbits. Animals given saturated-fat diets show significant immuno-detectable cerebral A&#x003b2; burden [<xref ref-type="bibr" rid="B18">18</xref>-<xref ref-type="bibr" rid="B20">20</xref>], although the mechanisms by which this occurs are presently unclear.</p><p>Our laboratory recently reported that absorptive epithelial cells of the small intestine secrete A&#x003b2; associated with dietary-derived lipoproteins (chylomicrons) [<xref ref-type="bibr" rid="B21">21</xref>]. A diet enriched in saturated fats and cholesterol was found to markedly increase enterocytic A&#x003b2;, whereas fasting completely abolished A&#x003b2; production. Chronic ingestion of saturated-fat may lead to sustained elevations in blood of lipoprotein-bound A&#x003b2;, because of overproduction and thereafter, reduced clearance from blood. Moreover, recent studies suggest that exaggerated exposure to circulating A&#x003b2; may compromise blood-brain-barrier integrity and exacerbate cerebral amyloidosis [<xref ref-type="bibr" rid="B22">22</xref>]. In normal subjects, approximately 60% of lipoprotein-bound plasma A&#x003b2; is associated with the triglyceride-rich-lipoproteins (TRL's) and in subjects with AD, post-absorptive accumulation of chylomicrons has been identified [<xref ref-type="bibr" rid="B23">23</xref>].</p><p>Apolipoprotein E is pivotal for the interaction of TRL with high affinity clearance pathways [<xref ref-type="bibr" rid="B12">12</xref>] including the low-density-lipoprotein-receptor (LDL-r) and LRP and will therefore significantly influence plasma lipoprotein-A&#x003b2; concentration and kinetics. However, apo E may also influence plasma A&#x003b2; homeostasis by modulating synthesis and secretion of the lipoprotein-A&#x003b2; complex from either the intestine and/or liver. To explore this concept further, in this study we compared enterocytic A&#x003b2; homeostasis in wild-type mice versus animals devoid of apo E (apo E knockouts). Mice were given either a low-fat, or high saturated-fat diet to explore synergistic effects. We find that apo E modulates intestinal morphology in a manner which may influence lipid absorptive capacity and has a synergistic effect with dietary fats on enterocytic A&#x003b2; homeostasis.</p></sec><sec><title>Results</title><sec><title>High-fat feeding induced hypercholesterolemia in apo E KO mice</title><p>Apo E KO mice given low-fat chow had significantly elevated plasma cholesterol compared to WT mice on the low-fat diet (table <xref ref-type="table" rid="T1">1</xref>), however plasma triglycerides were not significantly affected because of the gene deletion. In WT mice the high saturated fat diet had no significant affect on plasma cholesterol or triglycerides (table <xref ref-type="table" rid="T1">1</xref>). However, in apo E KO mice hypercholesterolemia was substantially exacerbated and some two-fold greater than the apo E KO mice given low-fat chow. All groups of mice gained weight during the intervention and there was no significant difference between treatment groups (data not shown).</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Plasma lipids in wild-type and apolipoprotein E knockout mice fed low and high fat diets</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">Diet</td><td align="center">Gene</td><td align="center">Cholesterol (mM) mean &#x000b1; S.E.M</td><td align="center">Triglyceride (mM) mean &#x000b1; S.E.M</td></tr></thead><tbody><tr><td align="center">LF</td><td align="center">WT</td><td align="center">2.1 &#x000b1; 0.05</td><td align="center">0.69 &#x000b1; 0.19</td></tr><tr><td align="center">LF</td><td align="center">Apo E KO</td><td align="center">*6.95 &#x000b1; 1.97</td><td align="center">0.68 &#x000b1; 0.09</td></tr><tr><td align="center">HF</td><td align="center">WT</td><td align="center">2.2 &#x000b1; 0.46</td><td align="center">0.42 &#x000b1; 0.12</td></tr><tr><td align="center">HF</td><td align="center">Apo E KO</td><td align="center">*14.3 &#x000b1; 0.01</td><td align="center">0.38 &#x000b1; 0.12</td></tr></tbody></table><table-wrap-foot><p>*<italic>P </italic>&#x0003c; 0.05</p><p>S.E.M = standard error of the mean</p><p>Table shows plasma cholesterol and triglyceride concentrations (mean &#x000b1; SEM, n = 6 mice per group) in C57BL/6J WT mice and apo E KO mice maintained on either LF or HF diet for six-months. Apo E KO mice had significantly elevated levels of plasma cholesterol compared to WT controls under both feeding regimens (P &#x0003c; 0.05). High-fat feeding further exacerbated the elevation of cholesterol in apo E KO mice compared to HF-WT (P &#x0003c; 0.001) and LF-APOE KO mice (P &#x0003c; 0.05). Plasma triglyceride was not significantly different between groups.</p></table-wrap-foot></table-wrap></sec><sec><title>Immunolocalisation of A&#x003b2; in the small intestine of apolipoprotein E KO mice: synergistic effects of high fat feeding</title><p>For all groups of mice, A&#x003b2; immunostaining was demonstrated within the perinuclear region of absorptive columnar epithelial cells of the small intestine mucosa (insert, figure <xref ref-type="fig" rid="F1">1</xref>). With low-fat feeding, WT and apo E KO mice exhibited positive staining of A&#x003b2; relatively evenly distributed throughout the mucosa epithelium. Apo E KO mice on low-fat diets showed a similar distribution of A&#x003b2; compared to WT controls (figure <xref ref-type="fig" rid="F1">1</xref>). The effect of high-fat feeding on enterocytic A&#x003b2; in WT and apo E KO mice is also given in figure <xref ref-type="fig" rid="F1">1</xref>. Both WT and apo E KO mice had significantly greater enterocytic A&#x003b2; abundance, however the effect was more pronounced in the apo E knockout group, notably with more enterocytes showing intense (3+) staining (double asterisks, figure <xref ref-type="fig" rid="F1">1</xref>).</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Enterocytic A&#x003b2; in wild-type and apolipoprotein E knockout mice given a high fat diet</bold>. Figure shows proportion of small intestinal epithelial cells with different staining intensity for A&#x003b2;. Score as follows: (-) no granular coloration, (+) modest with 1&#x02013;2 granules, (2+) moderate with 3&#x02013;4 granules or (3+) high, containing larger intense granules. Data was collected for six mice per group, with a minimum of four tissue sections per mouse studied. A minimum of 200 cells per section were scored and statistical significance was determined by one-way ANOVA with post-hoc Bonferroni test. LF-WT and LF-APOE KO mice have significantly (p &#x0003c; 0.05) fewer cells which stained positive for A&#x003b2; compared to mice fed high fats (HF-WT and HF-APOE KO *a and *b respectively). Under high-fat feeding, apo E KO mice had significantly greater proportion of cells which expressed A&#x003b2; at higher intensity compared to high-fat fed WT mice (*c, p &#x0003c; 0.05). The inset micrograph shows high-magnification of enterocytes from groups corresponding to graphs below. Beta-amyloid colocalized within the perinuclear regions of the cell containing Golgi and ER within enterocytes from all groups. (Scale bar = 20 &#x003bc;m).</p></caption><graphic xlink:href="1476-511X-7-15-1"/></fig></sec><sec><title>Villi height in apo E KO mice and effects of high fat feeding</title><p>Small intestinal villi length was determined as a surrogate marker of intestinal absorptive capacity. Apo E KO mice on the low-fat diet had significantly greater mean villi length compared to WT controls (figure <xref ref-type="fig" rid="F2">2</xref>). High-fat feeding was found to substantially increase villi length in control animals and was comparable to apo E KO mice. High-fat feeding had no synergistic influence on villi length in the absence of apo E expression (figure <xref ref-type="fig" rid="F2">2</xref>).</p><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Villi height in wild-type and apolipoprotein E knockout mice given a high fat diet</bold>. Mean villi height (mm) in WT and apo E KO mice fed low- and high-fat chow. LF-WT group had significantly (*p &#x0003c; 0.05) shorter villi height compared to other groups. The inset micrograph shows low-magnification of intestinal villi height for each group. (Scale bar = 200 &#x003bc;m).</p></caption><graphic xlink:href="1476-511X-7-15-2"/></fig></sec></sec><sec><title>Discussion</title><p>This study shows that in the absence of apo E, intestinal villi length is significantly greater than WT mice. The absence of apo E coupled with chronic ingestion of a saturated fat and cholesterol diet, increased enterocytic A&#x003b2; abundance compared to WT mice on a low-fat diet. This may have simply been a dietary-fat induced effect independent of apo E, because apo E KO mice on a low-fat diet showed similar levels of enterocytic A&#x003b2; compared to WT controls. On the other hand, the absence of apo E with a high-fat diet was found to enhance A&#x003b2; abundance above that observed in WT mice given saturates and cholesterol. The latter is consistent with modulation of A&#x003b2; by apo E that is lipid-threshold dependent.</p><p>Apolipoprotein E serves as a TRL ligand for both the LDL receptor and LRP [<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. The liver is a major source of apo E, however other tissues including the small intestine express apo E [<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref>]. Apo E KO mice [<xref ref-type="bibr" rid="B28">28</xref>-<xref ref-type="bibr" rid="B30">30</xref>] accumulate TRL's because they are unable to bind and be cleared by receptor processes [<xref ref-type="bibr" rid="B31">31</xref>]. Under low-fat feeding, apo E KO mice had a greater than three-fold increase in plasma. High-fat feeding exacerbated plasma cholesterol accumulation in apo E KO mice, presumably because of exaggerated lipoprotein production and indeed hypercholesterolemia was increased two-fold above low-fat fed apo E KO mice. Clearance of TRL's from blood is a two-step process requiring triglyceride lipolysis by lipases to produce a depleted apo E rich 'remnant' lipoprotein [<xref ref-type="bibr" rid="B24">24</xref>]. Thereafter, remnants are cleared by receptor pathways utilizing apo E as the ligand. There is no hydrolytic defect in apo E KO mice, which explains why these mice were not hypertriglyceridemic.</p><p>The mechanisms by which the absence of apo E increased enterocytic A&#x003b2; in high-fat fed mice are unclear, although studies in cell culture provide clues. Irizarry <italic>et al </italic>(2004) found that incubation of neuronal cells with apo E resulted in a reduced synthesis of A&#x003b2; by lowering the gamma secretase activity [<xref ref-type="bibr" rid="B4">4</xref>]. Rough endoplasmic reticulum (rER) and the Golgi compartments are where early endoplasmic cleavage of the A&#x003b2; precursor protein occurs, the latter consistent with increased enterocytic perinuclear A&#x003b2; immunostaining in apo E KO mice.</p><p>This study and others [<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B33">33</xref>] found longer villi length in apo E KO mice, suggestive of greater absorptive capacity. Greater substrate availability might stimulate A&#x003b2; biogenesis and this hypothesis is supported by the increase in A&#x003b2; abundance in high-fat WT mice which also had a marked increase in villus length. Greater A&#x003b2; abundance would have been expected in apo E KO mice given the low-fat diet compared to WT controls, because villus length was comparatively greater in the absence of the apo E gene. However, if lipid absorption is already efficient with the low-fat feeding regimen; the deletion of apo E (and increased villus length) would not necessarily have had the expected stimulatory effect on enterocytic A&#x003b2;.</p><p>Chylomicron synthesis occurs within the ER and Golgi requiring the progressive lipidation of apolipoprotein B<sub>48 </sub>(apo B<sub>48</sub>) [<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>]. Dietary fats transiently stimulate chylomicron synthesis and secretion [<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B37">37</xref>] and in clinical studies post-prandial elevations in the A&#x003b2;-precursor protein have been reported synergistic with the lipaemic response [<xref ref-type="bibr" rid="B3">3</xref>]. How A&#x003b2; binds and is secreted with chylomicron is unclear, although the protein is known to bind avidly with negatively charged hydrophobic lipids [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B38">38</xref>]. Cell culture studies also support a lipoprotein mediated secretory pathway because in hepatocyte media, A&#x003b2; is found associated with lipoprotein complexes [<xref ref-type="bibr" rid="B11">11</xref>].</p><p>In animal models and in cell cultures, apo E has confounding effects on hepatic secretion of VLDL. Apo E will normally suppress apo B production, but this is contradicted in the presence of lipids which strongly stimulate lipoprotein biogenesis [<xref ref-type="bibr" rid="B39">39</xref>]. In this study, enterocytic A&#x003b2; abundance was not significantly different in low-fat apo E KO mice compared to controls, suggesting that chylomicron synthetic rates were not different between these two groups of mice. The increased availability of dietary lipids when animals were fed the high-fat diet would promote chylomicron production and by extension, perhaps A&#x003b2; genesis. However, whilst enhanced enterocytic abundance of A&#x003b2; was seen in both WT and apo E KO mice given the high-fat diet, the effect was greater in the latter. One explanation is the finding that apo E normally suppresses triglyceride secretion from liver. Therefore, the enhanced effect on enterocytic A&#x003b2; seen in apo E KO given high-fat may have been indicative of amplification in the presence of greater cytosolic lipids [<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B40">40</xref>].</p></sec><sec><title>Conclusion</title><p>Many studies have demonstrated the central role of apo E in maintaining cerebral A&#x003b2; homeostasis including modulation of production, as a chaperone protein, and in maintaining efflux and influx pathways across the blood brain barrier. Furthermore, apo E profoundly influences the kinetics in blood of A&#x003b2; containing lipoproteins as well as their secretion from liver. This study now demonstrates that apo E may also regulate intestinal A&#x003b2; metabolism.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title>Animals</title><p>The protocols described were approved by an ethics committee accredited by the National Health and Medical Research Council of Australia (Curtin University ethics approval N 55-04). Six-week-old female C57BL/6J apolipoprotein E gene knockout (apo E KO) and wild-type (WT) mice weighing approximately 16 g were obtained from the Animal ARC, Perth, Western Australia. Mice were divided and randomly allocated into a low-fat or high-fat diet group. Mice were housed separately in a well-ventilated room that was maintained at 22&#x000b0;C on a 12:12-h light/dark cycles. Body weight was measured weekly.</p></sec><sec><title>Dietary regimen</title><p>Chow was purchased from Rodent Diet Specialty Feeds (Glen Forrest, Western Australia). The low-fat (control) group of mice was given chow that contained 4.0% (w/w) as unsaturated fat (AIN93M standard rodent diet) and the diet was free of cholesterol. Mice on the high-fat diet were given chow containing 1.0% (w/w) as unsaturated fat and 16.0% (w/w) as saturated fat (SF00&#x02013;245 high-fat mouse diet). In addition, the high-fat feed was supplemented with 1% (w/w) cholesterol and 0.5% (w/w) cholate, the latter to aid in absorption. The digestible energy for low-fat and high-fat feed were 15.2 MJ/kg and 18.7 MJ/kg respectively. Food and water were available <italic>ad libitum</italic>.</p></sec><sec><title>Sample collection</title><p>After six-months of dietary interventions, mice were anaesthetized with an intraperitoneal injection of Phenobarbital (45 mg/kg). Mice were exsanguinated by cardiac punctureand blood was collected into ethylene-diamine-tetracetic acid (EDTA)-tubes. Plasma was separated by low speed centrifugation and stored at -80&#x000b0;C (under an atmosphere of argon).</p></sec><sec><title>Tissue processing</title><p>A small intestine segment measuring 2 cm was cut and isolated from the rest of the digestive tract at the proximal duodenal sphincter. The contents were flushed <italic>in-situ </italic>with phosphate buffered saline (PBS, pH = 7.4), and placed into 10% buffered formalin (ph = 7.4) for fixation. Tissues were fixed for 24 h and processed for immunohistochemistry (IHC).</p></sec><sec><title>Immunohistochemistry</title><p>Tissue sections (5 &#x003bc;m) were deparaffinised, rehydrated and IHC analysis was done as previously described [<xref ref-type="bibr" rid="B21">21</xref>]. Briefly, the sections were exposed to 3% hydrogen peroxide in methanol for 30 min to quench endogenous peroxidase activity, washed and incubated in blocking serum (20% goat serum) prior to overnight incubation at 4&#x000b0;C with polyclonal rabbit anti-human A&#x003b2;<sub>1&#x02013;40/42 </sub>antiserum (AB5076, Chemicon Temecula, CA), diluted to 1:1000 with 10% goat serum. We previously established specificity by replacing the primary antibody with an irrelevant serum or with PBS and by competition IHC analysis [<xref ref-type="bibr" rid="B21">21</xref>]. For the latter, the primary antisera were pre-mixed with solubilised A&#x003b2;. Cerebral tissues from transgenic mice (Tg2576sw) expressing familial human APP695 with established plaques were used as positive controls. Slides were washed in PBS and incubated with biotinylated goat anti-rabbit secondary antibody (1:1000 dilution) (E 0432, DAKO, Carpinteria, CA), followed by avidin-biotin-peroxidase complex (ABC/HRP) (K 0377, DAKO, Carpinteria, CA) for 45 min at room temperature. Positive immunostaining was established with liquid diaminobenzidine plus (DAB+) substrate chromogen kit (K 3467, DAKO, Carpinteria, CA). Sections were then counterstained with Harris's haematoxylin.</p></sec><sec><title>Imaging</title><p>Digital images for photomicroscopy were acquired by AxioCam HRc camera (Zeiss Germany). Images were captured under identical settings utilising AxioVision software, version 4.5.</p></sec><sec><title>Quantitation of intestinal beta-amyloid abundance</title><p>Six animals per group were investigated with a minimum of four tissue blocks prepared for each. From each slide, four images were captured randomly at low magnification (Zeiss AxioVert 200 M, Germany). The intensity of immunolabeling was quantified as previously described [<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref>]. Labelling was considered adequate if it was mild (+), moderate (2+), or intense (3+), with adequately labeled positive controls and no labeling in negative controls. The total number of cells with different intensity of A&#x003b2; staining was counted by a blinded-to-group investigator in each villus and the data expressed as a percentage.</p></sec><sec><title>Measurements of intestinal villi height</title><p>Total of 8 images was taken at low-magnification per group. Representative villi were selected by two independent investigators for height measurement (measurement tool, AxioVision program 4.5).</p></sec><sec><title>Plasma lipid measurements</title><p>Plasma lipids were measured immediately following plasma isolation via commercial absorbance-based assays. Triglyceride was determined by measurement of glycerol liberated following enzymatic hydrolysis of triglyceride (TR 1697, Randox laboratories, U.K). Total plasma cholesterol concentration was determined via the cholesterol esterase/cholesterol oxidase technique (CH 201, Randox laboratories, U.K).</p></sec><sec><title>Statistical analysis</title><p>The effect of high-fat feeding and apo E gene on A&#x003b2; abundance, intestinal villi height, plasma triglyceride and total cholesterol was assessed by univariate analysis. Post-hoc comparisons of means were performed using Bonferroni tests and if equal variance was not found, then Games-Howell test was used to compare difference between individual groups. P-value &#x0003c; 0.05 was considered a statistically significant.</p></sec></sec><sec><title>List of abbreviations</title><p>A&#x003b2;: beta-amyloid; AD: Alzheimer's disease; Apo: apolipoprotein; APP: amyloid precursor protein; CH: cholesterol; IHC: immunohistochemistry; KO: knockout; TG: triglycerides; TRL: triglyceride-rich-lipoprotein; WT: wild-type.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>SG participated in the design of the study, carried out the study, performed the IHC and lipid analysis and helped to draft the manuscript. MMSPG helped to collect data for results analysis. RT helped to collect data for results analysis. LJ participated in the design of study and performed the statistical analysis. RDJ participated in design of study and helped to draft the manuscript. SSD helped with performing statistical analysis. JCLM participated in the design of the study, performed statistical analysis, and coordinated and helped to draft the manuscript. All authors read and approved the final manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>The authors would like to thank Columbur Cheung and Karl Fairhurst for technical assistance.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>DeMattos</surname><given-names>RB</given-names></name></person-group><article-title>Apolipoprotein E dose-dependent modulation of beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease</article-title><source>J Mol Neurosci</source><year>2004</year><volume>23</volume><fpage>255</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">15181254</pub-id><pub-id pub-id-type="doi">10.1385/JMN:23:3:255</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bales</surname><given-names>KR</given-names></name><name><surname>Verina</surname><given-names>T</given-names></name><name><surname>Cummins</surname><given-names>DJ</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Dodel</surname><given-names>RC</given-names></name><name><surname>Saura</surname><given-names>J</given-names></name><name><surname>Fishman</surname><given-names>CE</given-names></name><name><surname>DeLong</surname><given-names>CA</given-names></name><name><surname>Piccardo</surname><given-names>P</given-names></name><name><surname>Petegnief</surname><given-names>V</given-names></name><name><surname>Ghetti</surname><given-names>B</given-names></name><name><surname>Paul</surname><given-names>SM</given-names></name></person-group><article-title>Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease</article-title><source>Proc Natl Acad Sci U S A</source><year>1999</year><volume>96</volume><fpage>15233</fpage><lpage>15238</lpage><pub-id pub-id-type="pmid">10611368</pub-id><pub-id pub-id-type="doi">10.1073/pnas.96.26.15233</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boyt</surname><given-names>AA</given-names></name><name><surname>Taddei</surname><given-names>K</given-names></name><name><surname>Hallmayer</surname><given-names>J</given-names></name><name><surname>Mamo</surname><given-names>J</given-names></name><name><surname>Helmerhorst</surname><given-names>E</given-names></name><name><surname>Gandy</surname><given-names>SE</given-names></name><name><surname>Martins</surname><given-names>RN</given-names></name></person-group><article-title>Relationship between lipid metabolism and amyloid precursor protein and apolipoprotein E</article-title><source>Alzheimer's Reports</source><year>1999</year><volume>2</volume><fpage>339</fpage><lpage>346</lpage></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Irizarry</surname><given-names>MC</given-names></name><name><surname>Deng</surname><given-names>A</given-names></name><name><surname>Lleo</surname><given-names>A</given-names></name><name><surname>Berezovska</surname><given-names>O</given-names></name><name><surname>Von Arnim</surname><given-names>CA</given-names></name><name><surname>Martin-Rehrmann</surname><given-names>M</given-names></name><name><surname>Manelli</surname><given-names>A</given-names></name><name><surname>LaDu</surname><given-names>MJ</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name><name><surname>Rebeck</surname><given-names>GW</given-names></name></person-group><article-title>Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein</article-title><source>J Neurochem</source><year>2004</year><volume>90</volume><fpage>1132</fpage><lpage>1143</lpage><pub-id pub-id-type="pmid">15312168</pub-id><pub-id pub-id-type="doi">10.1111/j.1471-4159.2004.02581.x</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>AP</given-names></name><name><surname>Pal</surname><given-names>S</given-names></name><name><surname>Gennat</surname><given-names>HC</given-names></name><name><surname>Vine</surname><given-names>DF</given-names></name><name><surname>Mamo</surname><given-names>JC</given-names></name></person-group><article-title>The incorporation and metabolism of amyloid-beta into chylomicron-like lipid emulsions</article-title><source>J Alzheimers Dis</source><year>2003</year><volume>5</volume><fpage>179</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">12897403</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>LaDu</surname><given-names>MJ</given-names></name><name><surname>Lukens</surname><given-names>JR</given-names></name><name><surname>Reardon</surname><given-names>CA</given-names></name><name><surname>Getz</surname><given-names>GS</given-names></name></person-group><article-title>Association of human, rat, and rabbit apolipoprotein E with beta-amyloid</article-title><source>J Neurosci Res</source><year>1997</year><volume>49</volume><fpage>9</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">9211985</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1097-4547(19970701)49:1&#x0003c;9::AID-JNR2&#x0003e;3.0.CO;2-H</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strittmatter</surname><given-names>WJ</given-names></name><name><surname>Weisgraber</surname><given-names>KH</given-names></name><name><surname>Huang</surname><given-names>DY</given-names></name><name><surname>Dong</surname><given-names>LM</given-names></name><name><surname>Salvesen</surname><given-names>GS</given-names></name><name><surname>Pericak-Vance</surname><given-names>M</given-names></name><name><surname>Schmechel</surname><given-names>D</given-names></name><name><surname>Saunders</surname><given-names>AM</given-names></name><name><surname>Goldgaber</surname><given-names>D</given-names></name><name><surname>Roses</surname><given-names>AD</given-names></name></person-group><article-title>Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease</article-title><source>Proc Natl Acad Sci U S A</source><year>1993</year><volume>90</volume><fpage>8098</fpage><lpage>8102</lpage><pub-id pub-id-type="pmid">8367470</pub-id><pub-id pub-id-type="doi">10.1073/pnas.90.17.8098</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Mullendorff</surname><given-names>K</given-names></name><name><surname>Dong</surname><given-names>L</given-names></name><name><surname>Giedt</surname><given-names>G</given-names></name><name><surname>Meng</surname><given-names>EC</given-names></name><name><surname>Cohen</surname><given-names>FE</given-names></name><name><surname>Kuntz</surname><given-names>ID</given-names></name><name><surname>Weisgraber</surname><given-names>KH</given-names></name><name><surname>Mahley</surname><given-names>RW</given-names></name></person-group><article-title>Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target</article-title><source>Proc Natl Acad Sci U S A</source><year>2005</year><volume>102</volume><fpage>18700</fpage><lpage>18705</lpage><pub-id pub-id-type="pmid">16344478</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0508693102</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deane</surname><given-names>R</given-names></name><name><surname>Du Yan</surname><given-names>S</given-names></name><name><surname>Submamaryan</surname><given-names>RK</given-names></name><name><surname>LaRue</surname><given-names>B</given-names></name><name><surname>Jovanovic</surname><given-names>S</given-names></name><name><surname>Hogg</surname><given-names>E</given-names></name><name><surname>Welch</surname><given-names>D</given-names></name><name><surname>Manness</surname><given-names>L</given-names></name><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Ghiso</surname><given-names>J</given-names></name><name><surname>Frangione</surname><given-names>B</given-names></name><name><surname>Stern</surname><given-names>A</given-names></name><name><surname>Schmidt</surname><given-names>AM</given-names></name><name><surname>Armstrong</surname><given-names>DL</given-names></name><name><surname>Arnold</surname><given-names>B</given-names></name><name><surname>Liliensiek</surname><given-names>B</given-names></name><name><surname>Nawroth</surname><given-names>P</given-names></name><name><surname>Hofman</surname><given-names>F</given-names></name><name><surname>Kindy</surname><given-names>M</given-names></name><name><surname>Stern</surname><given-names>D</given-names></name><name><surname>Zlokovic</surname><given-names>B</given-names></name></person-group><article-title>RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain</article-title><source>Nat Med</source><year>2003</year><volume>9</volume><fpage>907</fpage><lpage>913</lpage><pub-id pub-id-type="pmid">12808450</pub-id><pub-id pub-id-type="doi">10.1038/nm890</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dodart</surname><given-names>JC</given-names></name><name><surname>Bales</surname><given-names>KR</given-names></name><name><surname>Gannon</surname><given-names>KS</given-names></name><name><surname>Greene</surname><given-names>SJ</given-names></name><name><surname>DeMattos</surname><given-names>RB</given-names></name><name><surname>Mathis</surname><given-names>C</given-names></name><name><surname>DeLong</surname><given-names>CA</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Holtzman</surname><given-names>DM</given-names></name><name><surname>Paul</surname><given-names>SM</given-names></name></person-group><article-title>Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model</article-title><source>Nat Neurosci</source><year>2002</year><volume>5</volume><fpage>452</fpage><lpage>457</lpage><pub-id pub-id-type="pmid">11941374</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koudinov</surname><given-names>AR</given-names></name><name><surname>Koudinova</surname><given-names>NV</given-names></name></person-group><article-title>Alzheimer's soluble amyloid beta protein is secreted by HepG2 cells as an apolipoprotein</article-title><source>Cell Biol Int</source><year>1997</year><volume>21</volume><fpage>265</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">9243801</pub-id><pub-id pub-id-type="doi">10.1006/cbir.1996.0126</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mahley</surname><given-names>RW</given-names></name></person-group><article-title>Apolipoprotein E: cholesterol transport protein with expanding role in cell biology</article-title><source>Science</source><year>1988</year><volume>240</volume><fpage>622</fpage><lpage>630</lpage><pub-id pub-id-type="pmid">3283935</pub-id><pub-id pub-id-type="doi">10.1126/science.3283935</pub-id></citation></ref><ref id="B13"><citation citation-type="other"></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>MC</given-names></name><name><surname>Evans</surname><given-names>DA</given-names></name><name><surname>Bienias</surname><given-names>JL</given-names></name><name><surname>Tangney</surname><given-names>CC</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name><name><surname>Aggarwal</surname><given-names>N</given-names></name><name><surname>Schneider</surname><given-names>J</given-names></name><name><surname>Wilson</surname><given-names>RS</given-names></name></person-group><article-title>Dietary fats and the risk of incident Alzheimer disease</article-title><source>Arch Neurol</source><year>2003</year><volume>60</volume><fpage>194</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">12580703</pub-id><pub-id pub-id-type="doi">10.1001/archneur.60.2.194</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalmijn</surname><given-names>S</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><name><surname>Ott</surname><given-names>A</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Breteler</surname><given-names>MM</given-names></name></person-group><article-title>Dietary fat intake and the risk of incident dementia in the Rotterdam Study</article-title><source>Ann Neurol</source><year>1997</year><volume>42</volume><fpage>776</fpage><lpage>782</lpage><pub-id pub-id-type="pmid">9392577</pub-id><pub-id pub-id-type="doi">10.1002/ana.410420514</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Engelhart</surname><given-names>MJ</given-names></name><name><surname>Geerlings</surname><given-names>MI</given-names></name><name><surname>Ruitenberg</surname><given-names>A</given-names></name><name><surname>Van Swieten</surname><given-names>JC</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name><name><surname>Breteler</surname><given-names>MM</given-names></name></person-group><article-title>Diet and risk of dementia: Does fat matter?: The Rotterdam Study</article-title><source>Neurology</source><year>2002</year><volume>59</volume><fpage>1915</fpage><lpage>1921</lpage><pub-id pub-id-type="pmid">12499483</pub-id><pub-id pub-id-type="doi">10.1001/archneur.59.12.1915</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luchsinger</surname><given-names>JA</given-names></name><name><surname>Mayeux</surname><given-names>R</given-names></name></person-group><article-title>Dietary factors and Alzheimer's disease</article-title><source>Lancet Neurol</source><year>2004</year><volume>3</volume><fpage>579</fpage><lpage>587</lpage><pub-id pub-id-type="pmid">15380154</pub-id><pub-id pub-id-type="doi">10.1016/S1474-4422(04)00878-6</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Solfrizzi</surname><given-names>V</given-names></name><name><surname>D'Introno</surname><given-names>A</given-names></name><name><surname>Colacicco</surname><given-names>AM</given-names></name><name><surname>Capurso</surname><given-names>C</given-names></name><name><surname>Del Parigi</surname><given-names>A</given-names></name><name><surname>Capurso</surname><given-names>S</given-names></name><name><surname>Gadaleta</surname><given-names>A</given-names></name><name><surname>Capurso</surname><given-names>A</given-names></name><name><surname>Panza</surname><given-names>F</given-names></name></person-group><article-title>Dietary fatty acids intake: possible role in cognitive decline and dementia</article-title><source>Exp Gerontol</source><year>2005</year><volume>40</volume><fpage>257</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">15820606</pub-id><pub-id pub-id-type="doi">10.1016/j.exger.2005.01.001</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sparks</surname><given-names>DL</given-names></name><name><surname>Scheff</surname><given-names>SW</given-names></name><name><surname>Hunsaker</surname><given-names>JC</given-names><suffix>3rd</suffix></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Landers</surname><given-names>T</given-names></name><name><surname>Gross</surname><given-names>DR</given-names></name></person-group><article-title>Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol</article-title><source>Exp Neurol</source><year>1994</year><volume>126</volume><fpage>88</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">8157129</pub-id><pub-id pub-id-type="doi">10.1006/exnr.1994.1044</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Refolo</surname><given-names>LM</given-names></name><name><surname>Malester</surname><given-names>B</given-names></name><name><surname>LaFrancois</surname><given-names>J</given-names></name><name><surname>Bryant-Thomas</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Tint</surname><given-names>GS</given-names></name><name><surname>Sambamurti</surname><given-names>K</given-names></name><name><surname>Duff</surname><given-names>K</given-names></name><name><surname>Pappolla</surname><given-names>MA</given-names></name></person-group><article-title>Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model</article-title><source>Neurobiol Dis</source><year>2000</year><volume>7</volume><fpage>321</fpage><lpage>331</lpage><pub-id pub-id-type="pmid">10964604</pub-id><pub-id pub-id-type="doi">10.1006/nbdi.2000.0304</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shie</surname><given-names>FS</given-names></name><name><surname>Jin</surname><given-names>LW</given-names></name><name><surname>Cook</surname><given-names>DG</given-names></name><name><surname>Leverenz</surname><given-names>JB</given-names></name><name><surname>LeBoeuf</surname><given-names>RC</given-names></name></person-group><article-title>Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice</article-title><source>Neuroreport</source><year>2002</year><volume>13</volume><fpage>455</fpage><lpage>459</lpage><pub-id pub-id-type="pmid">11930160</pub-id><pub-id pub-id-type="doi">10.1097/00001756-200203250-00019</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galloway</surname><given-names>S</given-names></name><name><surname>Le</surname><given-names>J</given-names></name><name><surname>Johnsen</surname><given-names>R</given-names></name><name><surname>Chew</surname><given-names>S</given-names></name><name><surname>Mamo</surname><given-names>JCL</given-names></name></person-group><article-title>Beta-amyloid or its precursor protein is found in epithelial cells of the small intestine and stimulated by high fat feeding.</article-title><source>Journal of Nutritional Biochemistry</source><year>2006</year><volume>In press</volume></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>GC</given-names></name><name><surname>Arendash</surname><given-names>GW</given-names></name><name><surname>Kalaria</surname><given-names>RN</given-names></name><name><surname>Bjugstad</surname><given-names>KB</given-names></name><name><surname>Mullan</surname><given-names>M</given-names></name></person-group><article-title>Intravascular infusions of soluble beta-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhage</article-title><source>Brain Res</source><year>1999</year><volume>818</volume><fpage>105</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">9914443</pub-id><pub-id pub-id-type="doi">10.1016/S0006-8993(98)01143-3</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mahley</surname><given-names>RW</given-names></name><name><surname>Hui</surname><given-names>DY</given-names></name><name><surname>Innerarity</surname><given-names>TL</given-names></name><name><surname>Weisgraber</surname><given-names>KH</given-names></name></person-group><article-title>Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptors</article-title><source>J Clin Invest</source><year>1981</year><volume>68</volume><fpage>1197</fpage><lpage>1206</lpage><pub-id pub-id-type="pmid">6271808</pub-id><pub-id pub-id-type="doi">10.1172/JCI110365</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>DY</given-names></name><name><surname>Innerarity</surname><given-names>TL</given-names></name><name><surname>Mahley</surname><given-names>RW</given-names></name></person-group><article-title>Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors</article-title><source>J Biol Chem</source><year>1981</year><volume>256</volume><fpage>5646</fpage><lpage>5655</lpage><pub-id pub-id-type="pmid">6263887</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Driscoll</surname><given-names>DM</given-names></name><name><surname>Getz</surname><given-names>GS</given-names></name></person-group><article-title>Extrahepatic synthesis of apolipoprotein E</article-title><source>J Lipid Res</source><year>1984</year><volume>25</volume><fpage>1368</fpage><lpage>1379</lpage><pub-id pub-id-type="pmid">6530593</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Emanuele</surname><given-names>E</given-names></name><name><surname>Peros</surname><given-names>E</given-names></name><name><surname>Tomaino</surname><given-names>C</given-names></name><name><surname>Feudatari</surname><given-names>E</given-names></name><name><surname>Bernardi</surname><given-names>L</given-names></name><name><surname>Binetti</surname><given-names>G</given-names></name><name><surname>Maletta</surname><given-names>R</given-names></name><name><surname>D'Angelo</surname><given-names>A</given-names></name><name><surname>Montagna</surname><given-names>L</given-names></name><name><surname>Bruni</surname><given-names>AC</given-names></name><name><surname>Geroldi</surname><given-names>D</given-names></name></person-group><article-title>Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's disease</article-title><source>Neurosci Lett</source><year>2004</year><volume>357</volume><fpage>45</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">15036610</pub-id><pub-id pub-id-type="doi">10.1016/j.neulet.2003.12.043</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>SH</given-names></name><name><surname>Reddick</surname><given-names>RL</given-names></name><name><surname>Piedrahita</surname><given-names>JA</given-names></name><name><surname>Maeda</surname><given-names>N</given-names></name></person-group><article-title>Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E</article-title><source>Science</source><year>1992</year><volume>258</volume><fpage>468</fpage><lpage>471</lpage><pub-id pub-id-type="pmid">1411543</pub-id><pub-id pub-id-type="doi">10.1126/science.1411543</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Plump</surname><given-names>AS</given-names></name><name><surname>Smith</surname><given-names>JD</given-names></name><name><surname>Hayek</surname><given-names>T</given-names></name><name><surname>Aalto-Setala</surname><given-names>K</given-names></name><name><surname>Walsh</surname><given-names>A</given-names></name><name><surname>Verstuyft</surname><given-names>JG</given-names></name><name><surname>Rubin</surname><given-names>EM</given-names></name><name><surname>Breslow</surname><given-names>JL</given-names></name></person-group><article-title>Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells</article-title><source>Cell</source><year>1992</year><volume>71</volume><fpage>343</fpage><lpage>353</lpage><pub-id pub-id-type="pmid">1423598</pub-id><pub-id pub-id-type="doi">10.1016/0092-8674(92)90362-G</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakashima</surname><given-names>Y</given-names></name><name><surname>Plump</surname><given-names>AS</given-names></name><name><surname>Raines</surname><given-names>EW</given-names></name><name><surname>Breslow</surname><given-names>JL</given-names></name><name><surname>Ross</surname><given-names>R</given-names></name></person-group><article-title>ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree</article-title><source>Arterioscler Thromb</source><year>1994</year><volume>14</volume><fpage>133</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">8274468</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hultin</surname><given-names>M</given-names></name><name><surname>Olivecrona</surname><given-names>T</given-names></name></person-group><article-title>Conversion of chylomicrons into remnants</article-title><source>Atherosclerosis</source><year>1998</year><volume>141</volume><fpage>25</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/S0021-9150(98)00229-9</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kanemitsu</surname><given-names>N</given-names></name><name><surname>Shimamoto</surname><given-names>C</given-names></name><name><surname>Hiraike</surname><given-names>Y</given-names></name><name><surname>Omae</surname><given-names>T</given-names></name><name><surname>Iwakura</surname><given-names>K</given-names></name><name><surname>Nakanishi</surname><given-names>Y</given-names></name><name><surname>Katsu</surname><given-names>K</given-names></name></person-group><article-title>Fat Absorption and Morphological Changes in the Small Intestine in Model Mice with Hyperlipidemia (Apo E Deficiency)</article-title><source>Bulletin of the Osaka Medical College</source><year>2006</year><volume>52</volume><fpage>59</fpage><lpage>67</lpage></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kesaniemi</surname><given-names>YA</given-names></name><name><surname>Ehnholm</surname><given-names>C</given-names></name><name><surname>Miettinen</surname><given-names>TA</given-names></name></person-group><article-title>Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype</article-title><source>J Clin Invest</source><year>1987</year><volume>80</volume><fpage>578</fpage><lpage>581</lpage><pub-id pub-id-type="pmid">3611358</pub-id><pub-id pub-id-type="doi">10.1172/JCI113107</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hussain</surname><given-names>MM</given-names></name><name><surname>Kedees</surname><given-names>MH</given-names></name><name><surname>Singh</surname><given-names>K</given-names></name><name><surname>Athar</surname><given-names>H</given-names></name><name><surname>Jamali</surname><given-names>NZ</given-names></name></person-group><article-title>Signposts in the assembly of chylomicrons</article-title><source>Front Biosci</source><year>2001</year><volume>6</volume><fpage>D320</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">11229873</pub-id><pub-id pub-id-type="doi">10.2741/Hussain</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Greevenbroek</surname><given-names>MM</given-names></name><name><surname>van Meer</surname><given-names>G</given-names></name><name><surname>Erkelens</surname><given-names>DW</given-names></name><name><surname>de Bruin</surname><given-names>TW</given-names></name></person-group><article-title>Effects of saturated, mono-, and polyunsaturated fatty acids on the secretion of apo B containing lipoproteins by Caco-2 cells</article-title><source>Atherosclerosis</source><year>1996</year><volume>121</volume><fpage>139</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">8678919</pub-id><pub-id pub-id-type="doi">10.1016/0021-9150(95)05712-9</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Greevenbroek</surname><given-names>MM</given-names></name><name><surname>de Bruin</surname><given-names>TW</given-names></name></person-group><article-title>Chylomicron synthesis by intestinal cells in vitro and in vivo</article-title><source>Atherosclerosis</source><year>1998</year><volume>141 Suppl 1</volume><fpage>S9</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">9888636</pub-id><pub-id pub-id-type="doi">10.1016/S0021-9150(98)00212-3</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luchoomun</surname><given-names>J</given-names></name><name><surname>Hussain</surname><given-names>MM</given-names></name></person-group><article-title>Assembly and secretion of chylomicrons by differentiated Caco-2 cells. Nascent triglycerides and preformed phospholipids are preferentially used for lipoprotein assembly</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>19565</fpage><lpage>19572</lpage><pub-id pub-id-type="pmid">10391890</pub-id><pub-id pub-id-type="doi">10.1074/jbc.274.28.19565</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>H</given-names></name><name><surname>Jao</surname><given-names>SC</given-names></name><name><surname>Ma</surname><given-names>K</given-names></name><name><surname>Zagoriski</surname><given-names>MG</given-names></name></person-group><article-title>Solution Structures of Michelle-bound Amyloid beta1-40 and bet1-42 Peptides of Alzheimer's Disease</article-title><source>J Mol Biol</source><year>1999</year><volume>285</volume><fpage>755</fpage><lpage>773</lpage><pub-id pub-id-type="pmid">9878442</pub-id><pub-id pub-id-type="doi">10.1006/jmbi.1998.2348</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maugeais</surname><given-names>C</given-names></name><name><surname>Tietge</surname><given-names>UJ</given-names></name><name><surname>Tsukamoto</surname><given-names>K</given-names></name><name><surname>Glick</surname><given-names>JM</given-names></name><name><surname>Rader</surname><given-names>DJ</given-names></name></person-group><article-title>Hepatic apolipoprotein E expression promotes very low density lipoprotein-apolipoprotein B production in vivo in mice</article-title><source>J Lipid Res</source><year>2000</year><volume>41</volume><fpage>1673</fpage><lpage>1679</lpage><pub-id pub-id-type="pmid">11013310</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mensenkamp</surname><given-names>AR</given-names></name><name><surname>Van Luyn</surname><given-names>MJ</given-names></name><name><surname>Havinga</surname><given-names>R</given-names></name><name><surname>Teusink</surname><given-names>B</given-names></name><name><surname>Waterman</surname><given-names>IJ</given-names></name><name><surname>Mann</surname><given-names>CJ</given-names></name><name><surname>Elzinga</surname><given-names>BM</given-names></name><name><surname>Verkade</surname><given-names>HJ</given-names></name><name><surname>Zammit</surname><given-names>VA</given-names></name><name><surname>Havekes</surname><given-names>LM</given-names></name><name><surname>Shoulders</surname><given-names>CC</given-names></name><name><surname>Kuipers</surname><given-names>F</given-names></name></person-group><article-title>The transport of triglycerides through the secretory pathway of hepatocytes is impaired in apolipoprotein E deficient mice</article-title><source>J Hepatol</source><year>2004</year><volume>40</volume><fpage>599</fpage><lpage>606</lpage><pub-id pub-id-type="pmid">15030975</pub-id><pub-id pub-id-type="doi">10.1016/j.jhep.2003.12.011</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mikaelian</surname><given-names>I</given-names></name><name><surname>Nanney</surname><given-names>LB</given-names></name><name><surname>Parman</surname><given-names>KS</given-names></name><name><surname>Kusewitt</surname><given-names>DF</given-names></name><name><surname>Ward</surname><given-names>JM</given-names></name><name><surname>Naf</surname><given-names>D</given-names></name><name><surname>Krupke</surname><given-names>DM</given-names></name><name><surname>Eppig</surname><given-names>JT</given-names></name><name><surname>Bult</surname><given-names>CJ</given-names></name><name><surname>Seymour</surname><given-names>R</given-names></name><name><surname>Ichiki</surname><given-names>T</given-names></name><name><surname>Sundberg</surname><given-names>JP</given-names></name></person-group><article-title>Antibodies that label paraffin-embedded mouse tissues: a collaborative endeavor</article-title><source>Toxicol Pathol</source><year>2004</year><volume>32</volume><fpage>181</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">15200156</pub-id><pub-id pub-id-type="doi">10.1080/01926230490274335</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Donahue</surname><given-names>JE</given-names></name><name><surname>Flaherty</surname><given-names>SL</given-names></name><name><surname>Johanson</surname><given-names>CE</given-names></name><name><surname>Duncan</surname><given-names>JA</given-names><suffix>3rd</suffix></name><name><surname>Silverberg</surname><given-names>GD</given-names></name><name><surname>Miller</surname><given-names>MC</given-names></name><name><surname>Tavares</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Sabo</surname><given-names>E</given-names></name><name><surname>Hovanesian</surname><given-names>V</given-names></name><name><surname>Stopa</surname><given-names>EG</given-names></name></person-group><article-title>RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease</article-title><source>Acta Neuropathol</source><year>2006</year><volume>112</volume><fpage>405</fpage><lpage>415</lpage><pub-id pub-id-type="pmid">16865397</pub-id><pub-id pub-id-type="doi">10.1007/s00401-006-0115-3</pub-id></citation></ref></ref-list></back></article> 